American Well (NYSE:AMWL) Releases Quarterly Earnings Results, Beats Expectations By $0.60 EPS

Key Points

• American Well reported a quarterly earnings per share of ($1.24), beating the consensus estimate by $0.66.
• The company's stock price rose to $8.48 following the earnings announcement, with increased trading volume of 265,554 shares.
• Jane Street Group LLC increased its stake in American Well by 232.9% during the first quarter, highlighting growing institutional interest in the company.

American Well (NYSE:AMWL - Get Free Report) issued its quarterly earnings data on Tuesday. The company reported ($1.24) earnings per share for the quarter, topping the consensus estimate of ($1.84) by $0.60, Zacks reports. American Well had a negative net margin of 46.15% and a negative return on equity of 41.99%. The company had revenue of $70.90 million for the quarter, compared to analysts' expectations of $63.87 million. American Well updated its Q3 2025 guidance to EPS and its FY 2025 guidance to EPS.

American Well Stock Down 1.7%

NYSE:AMWL traded down $0.12 during trading hours on Friday, hitting $7.24. 65,361 shares of the company traded hands, compared to its average volume of 77,356. The firm's 50-day simple moving average is $7.73 and its 200-day simple moving average is $8.26. American Well has a one year low of $6.09 and a one year high of $12.95. The company has a market cap of $112.95 million, a PE ratio of -0.90 and a beta of 1.28.

Insiders Place Their Bets

In other American Well news, insider Phyllis Gotlib sold 4,958 shares of the stock in a transaction dated Tuesday, July 1st. The shares were sold at an average price of $8.63, for a total value of $42,787.54. Following the completion of the sale, the insider owned 136,891 shares in the company, valued at approximately $1,181,369.33. This trade represents a 3.50% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. In the last quarter, insiders sold 10,184 shares of company stock worth $78,000. 11.82% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On American Well

An institutional investor recently raised its position in American Well stock. Goldman Sachs Group Inc. grew its stake in shares of American Well Corporation (NYSE:AMWL - Free Report) by 280.6% in the first quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 64,760 shares of the company's stock after acquiring an additional 47,745 shares during the period. Goldman Sachs Group Inc. owned about 0.41% of American Well worth $510,000 at the end of the most recent reporting period. Institutional investors own 56.05% of the company's stock.

Wall Street Analysts Forecast Growth

Several analysts recently weighed in on AMWL shares. Needham & Company LLC reissued a "hold" rating on shares of American Well in a research note on Friday, May 2nd. UBS Group dropped their target price on shares of American Well from $12.00 to $9.00 and set a "neutral" rating on the stock in a report on Thursday, May 8th. Piper Sandler restated a "neutral" rating and issued a $8.00 target price (down previously from $10.00) on shares of American Well in a report on Friday, May 23rd. Stifel Nicolaus dropped their target price on shares of American Well from $10.00 to $8.00 and set a "hold" rating on the stock in a report on Friday, May 2nd. Finally, Wells Fargo & Company dropped their target price on shares of American Well from $15.00 to $12.00 and set an "overweight" rating on the stock in a report on Thursday. Six research analysts have rated the stock with a hold rating and one has assigned a buy rating to the stock. According to data from MarketBeat.com, American Well currently has an average rating of "Hold" and a consensus price target of $9.17.

About American Well

American Well Corporation, an enterprise platform and software company, delivers digitally enabling hybrid care in the United States and internationally. The company offers Converge, a cloud-based platform that enables health providers, payers, and innovators to provide in-person, virtual and automated care; and delivers virtual primary care, post-discharge follow-up, chronic condition management, virtual nursing, e-sitting, on-demand and scheduled virtual visits, specialty consults, automated care, and behavioral health, as well as specialty care programs, including dermatology, musculoskeletal care, second opinion, and cardiometabolic care to patients and members.